
Adicet Bio
Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
About
Adicet Bio is a clinical-stage biotechnology company focused on discovering and developing off-the-shelf allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. Their proprietary platform engineers these cells with chimeric antigen receptors (CARs) to provide durable activity in patients. The company's lead product candidate, prulacabtagene leucel (prula-cel), is being developed for autoimmune indications and has received Fast Track Designation from the FDA for certain conditions.
Show 6 more similar companies
Similar companies
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Shares Biotech, Drug Discovery
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, HealthTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Shares Biotech, HealthTech
Biotech company developing next-generation gene writing tools for advanced therapies.
Shares Biotech, Oncology
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Adicet Bio?
People comparing tools land here. Get listed beside these.
Copy Adicet Bio's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- adicetbio.com
- Headquarters
- Boston, United States
- Founded
- 2014
- Founder
- Aya Jakobovits
- Total funding
- $389M (Registered Direct Offering)
- Business model
- B2B
Funding rounds
- $80M7 Oct 2025
- $98M25 Jan 2024Follow-on OfferingLargest round
- $80M2 Oct 2020
- $80M2 Oct 2019
- $51M27 Jan 2016
Led by OrbiMed
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 7 Oct 2025 | Registered Direct Offering | $80M | |
| 25 Jan 2024 | Follow-on Offering | $98M | |
| 2 Oct 2020 | Series B | $80M | |
| 2 Oct 2019 | Series B | $80M | |
| 27 Jan 2016 | Series A | $51M | OrbiMed |
Tech stack
Detected on adicetbio.com, last scanned 18 Nov 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- Hosting
- AWS
- Email provider
- Mimecast
- Cookie consent
- OneTrust
Benchmarking
See how your site ranks against 16,849 startups
Adicet Bio sits in the 51st percentile for Domain Rating. Check where yours lands, free.
Adicet Bio has a Domain Rating of 42, the 51st percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Bottom 25%
Scan yoursSite Speed
Below median
PageSpeedData Trust
Top 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Adicet Bio scores 23. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Adicet Bio changes
Used Adicet Bio? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns Adicet Bio?
Adicet Bio is privately held, owned by its founders and investors. OrbiMed has backed 2 of the 5 rounds on record since January 2016, ahead of Novartis Venture Fund (2) and Pontifax (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Are there companies like Adicet Bio?
Yes. We list 6 companies like Adicet Bio, including TippingPoint Biosciences, BeiGene and Cue Biopharma. Adicet Bio has raised more than 4 of the 6 with funding on record.
Is Adicet Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adicet Bio is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Adicet Bio raised?
Adicet Bio has raised a total of $389M in funding. The most recent round on record is Registered Direct Offering.
SEC filings, insider activity, nonprofit links and pay benchmarks for Adicet Bio:
Company details: from public sources. Funding: 5 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Adicet Bio and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

